BMPR2 and pulmonary arterial hypertension: In hereditary pulmonary arterial hypertension, BMPR2 mutations induce RV lipotoxicity, manifesting as FAO defects, triglyceride and ceramide deposition, leading to impaired RV hypertrophy and heart failure [50].